18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this protocol is to analyze the sensitivity and specificity of
18F-DTBZ PET to the differential diagnosis of Parkinson's Disease (PD) and normality.
Secondary, the investigators will analyze the correlation between the 18F-DTBZ binding and
the severity of disease of PD and the role of 18F-DTBZ PET in the monitoring disease
severity.